Shed vs Omzo: Name-Brand Options and Coaching vs Clinician-Guided Care
The Shed vs Omzo comparison focuses on medication options, clinical support style, pricing starting points, and regulatory notes. Early verdict: choose Shed if you want integrated coaching plus access to name-brand and compounded GLP-1; choose Omzo if you prefer a clinician-guided, primarily compounded program with a lower starting price.
How Shed and Omzo differ at a glance
This direct comparison highlights five supported differences between Shed and Omzo: medication type availability, clinical support model, starting price, compounded medication regulatory notes, and extras such as discounts or payment options.
1. Medication options: name-brand plus compounded vs primarily compounded
Shed offers both FDA-approved name-brand GLP-1 medications and compounded alternatives on one platform. Omzo primarily provides access to compounded semaglutide and tirzepatide through a compounded medication program, and notes that if a branded medication is prescribed a patient must fill that prescription at their chosen pharmacy.
2. Clinical support: integrated coaching vs clinician-guided plans
Shed integrates continuous coaching into treatment, positioning coaching as part of the monthly program rather than an add-on. Omzo emphasizes clinician-guided plans reviewed by licensed U.S. providers and states that providers make the final determination on prescriptions; Omzo also clarifies it is not a medical practice and clinical services are provided by third party networks.
3. Starting price and discounts
Both platforms list starting prices. Shed lists compounded semaglutide injections starting at $199/month and compounded tirzepatide injections starting at $299/month and advertises 10% off your first month. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 and notes medication costs are included in fees collected by Omzo for compounded programs.
4. Regulatory and packaging notes for compounded medications
Both providers explicitly note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Shed states compounded medications are made by a licensed pharmacy based on a provider’s prescription. Omzo states compounded drugs are prepared and shipped by a state-licensed sterile compounding pharmacy and are not FDA-approved.
5. Extras: assessment speed, payment options, and shipping
Shed advertises a 2-minute approval assessment and a coaching-bundled model. Omzo highlights fast, discreet delivery and lists FSA & HSA eligibility among its landing-page evidence; Omzo also cautions that eligibility, pharmacy, state coverage, and renewal terms may change.
| Criteria | Shed | Omzo |
|---|---|---|
| Medication types | Offers both FDA-approved name-brand and compounded GLP-1 options | Primarily offers compounded semaglutide & tirzepatide; providers may prescribe branded meds for you to fill |
| Clinical support | Continuous coaching integrated into treatment | Clinician-guided plans reviewed by licensed U.S. providers |
| Starting price (listed) | Compounded semaglutide starting at $199/month; tirzepatide starting at $299/month; 10% off first month | Semaglutide starting at $179; tirzepatide starting at $279 |
| Compounded drug regulatory note | Compounded medications are not FDA-approved; prepared by a licensed pharmacy | Compounded drugs are not FDA-approved; prepared and shipped by a state-licensed sterile compounding pharmacy |
| Payment/shipping extras | Coaching bundled into monthly cost; personalized quote after intake | Fast, discreet delivery; FSA & HSA eligible; medication costs included in Omzo fees for compounded program |
Deeper look: what these differences mean for you
If access to brand-name, FDA-approved GLP-1 options matters, Shed explicitly offers name-brand medications alongside compounded alternatives so you can choose based on budget and preference. Shed also emphasizes ongoing coaching to support titration and lifestyle changes. If a lower listed starting price for compounded semaglutide and clinician-led prescription decisions matter more, Omzo lists semaglutide starting at $179 and focuses on clinician-guided plans reviewed by U.S.-licensed providers.
What is not supplied in the source
The sources do not supply comparable standard pricing tables for name-brand medications, detailed membership or cancellation fees beyond the listed starts, or direct clinical outcome comparisons. Neither source guarantees specific weight-loss outcomes; both say results may vary and compounded drugs are not FDA-approved.
Shed vs Omzo: final thoughts
In short, Shed vs Omzo comes down to whether you prioritize integrated coaching plus the option of name-brand medications, or a clinician-guided, primarily compounded program with a lower starting price. Both platforms require a clinician review before prescriptions and both note compounded medications are not FDA-approved.
Choose Shed if…
- You want access to both FDA-approved name-brand GLP-1 options and compounded alternatives on one platform.
- You value continuous coaching integrated into treatment and a fast 2-minute eligibility assessment.
- You want a platform that advertises a 10% off first month offer.
Choose Omzo if…
- You prefer clinician-guided plans reviewed by licensed U.S. providers and a lower listed starting price for compounded semaglutide.
- You want a program that highlights fast, discreet delivery and notes FSA & HSA eligibility for its services.
For the primary comparison keyword, Shed vs Omzo, this side-by-side reflects only the facts supplied by each provider about medication options, support model, starting price, and regulatory notes.